How do femtech companies generate revenue?

This blog post has been written by the person who has mapped the femtech market in a clean and beautiful presentation

FemTech companies generate revenue through diverse monetization strategies that span digital subscriptions, direct-to-consumer sales, enterprise partnerships, and emerging platform models.

Understanding these revenue streams is crucial for entrepreneurs and investors entering this rapidly expanding market, where companies like Flo Health generate $200 million annually through freemium subscriptions while Maven Clinic captures $300 million in enterprise revenue. The key to success lies in choosing the right model for your target segment and scaling effectively.

And if you need to understand this market in 30 minutes with the latest information, you can download our quick market pitch.

What are the main ways femtech companies make money today?

FemTech companies primarily generate revenue through six core models: subscription-based digital services, direct-to-consumer product sales, B2B enterprise contracts, marketplace commissions, data monetization, and in-app purchases.

Subscription models dominate the digital landscape, with companies like Flo Health and Clue converting 5-10% of their free users to premium tiers at $30-60 annually. These apps gate advanced features like personalized insights, symptom prediction algorithms, and community access behind paywalls.

Enterprise B2B contracts represent the highest-margin revenue stream, where companies like Maven Clinic charge employers $100-300 per employee annually for fertility and family planning benefits. This model scales efficiently because employers subsidize costs and drive adoption at scale.

Direct-to-consumer sales focus on physical products like hormone testing kits, supplements, and wearable devices. Companies like Daye maintain 70%+ customer retention through monthly subscription boxes combining testing and treatment products.

Curious about how money is made in this sector? Explore the most profitable business models in our sleek decks.

Which specific products or services are currently the most profitable in the femtech industry?

Period-tracking apps with premium subscriptions generate the highest profit margins, with Flo Health's premium tier accounting for 60-70% of their $200 million annual revenue through personalized insights and community features.

Digital fertility and IVF platforms like Maven Clinic and Kindbody dominate enterprise revenue, generating $150-300 million annually through B2B telehealth contracts with employers and insurers. These platforms charge $200-500 per consultation while maintaining 80%+ gross margins.

Wearable devices combined with app subscriptions create dual revenue streams, with Elvie generating $100 million from hardware sales plus recurring income from app features and accessory purchases. The Elvie breast pump sells for $300-500 with 30%+ margins on replacement parts.

At-home testing kits paired with teleconsultations represent a fast-growing segment, where companies like Modern Fertility charge $159-199 per kit plus $89-150 for follow-up consultations. This model achieves 40-50% gross margins with strong repeat purchase rates.

Menopause and mental health apps using freemium models convert 5-10% of users to premium tiers, with successful apps like Gennev generating revenue through therapy sessions ($50-100 per session) and supplement sales with 60%+ margins.

If you want to build on this market, you can download our latest market pitch deck here

What are the different business models femtech companies typically use—like subscriptions, one-time sales, B2B vs B2C?

FemTech companies operate across distinct business model categories that determine their revenue structure, customer acquisition costs, and scaling potential.

How do femtech apps generate recurring revenue—through in-app purchases, ads, or premium features?

FemTech apps primarily generate recurring revenue through freemium-to-premium conversions, where 5-10% of free users upgrade to paid tiers at $30-60 annually for advanced features like personalized health insights and community access.

In-app purchases focus on modular content like guided meditation packs ($5-15), specialized workout programs ($10-25), or one-time consultations ($50-100). Mental health and menopause apps see the highest conversion rates for these micro-transactions.

Advertising partnerships with health brands generate revenue through native content integration, where carefully vetted supplement companies pay $2-5 per thousand impressions. However, most successful apps limit advertising to maintain user trust and premium positioning.

API and data services provide enterprise revenue streams, where apps license anonymized user data to research partners at $10,000-100,000 per dataset under strict GDPR and HIPAA compliance protocols.

Looking for the latest market trends? We break them down in sharp, digestible presentations you can skim or share.

Which femtech companies are the top performers in 2025, and what revenue models are they using?

Flo Health leads the market with 200 million users and $200 million annual revenue through a freemium subscription model, converting 6-8% of users to premium tiers with advanced cycle predictions and personalized health insights.

Maven Clinic dominates the B2B space with $300 million in enterprise revenue, charging employers $150-300 per employee annually for comprehensive fertility and family planning telehealth services. Their model scales efficiently with 80%+ gross margins on digital consultations.

Kindbody generates $150 million through a hybrid B2C clinic model combined with employer partnerships, offering IVF services at $15,000-25,000 per cycle while also providing workplace fertility benefits.

Elvie achieves $100 million in hardware revenue through premium breast pumps ($300-500) and pelvic floor trainers ($200-300), enhanced by subscription app features and high-margin replacement parts generating 30%+ additional revenue per customer.

Clue maintains strong performance with 15 million users and $50 million revenue through their science-based approach to menstrual tracking, charging $30-40 annually for premium features while maintaining high user engagement and retention rates.

Are there examples of femtech startups successfully using a marketplace or platform model?

Maven Clinic operates a successful marketplace connecting users to fertility specialists, charging referral fees of $50-200 per consultation plus platform subscription fees from healthcare providers seeking patient access.

Emerging clinical trial recruitment platforms represent a growing marketplace model, where companies match pharmaceutical sponsors with eligible female participants, earning $500-2,000 per successful referral depending on study complexity and duration.

Telehealth marketplaces like those within Kindbody's platform allow independent fertility specialists to offer services through the company's infrastructure, with revenue sharing arrangements typically splitting fees 70-30 between provider and platform.

Supplement and wellness marketplaces integrated within period-tracking apps generate commission revenue of 15-25% on third-party product sales, while maintaining quality control through curated vendor selection and user reviews.

Data marketplace platforms are emerging where aggregated, anonymized health data from multiple FemTech apps is licensed to pharmaceutical companies for $50,000-500,000 per research dataset, creating new revenue streams for established apps with large user bases.

If you want actionable data about this market, you can download our latest market pitch deck here

How do companies in femtech monetize health data ethically and legally?

FemTech companies monetize health data through strict consent frameworks requiring explicit opt-in permissions, transparent privacy policies, and granular controls allowing users to specify exactly what data can be shared and for what purposes.

Anonymization and aggregation protocols ensure individual users cannot be identified, with companies using irreversible de-identification techniques before selling datasets to certified research partners at $10,000-100,000 per study, depending on data richness and sample size.

Compliance with HIPAA (US) and GDPR (EU) standards requires dedicated privacy officers, regular audits, and data trust frameworks with independent oversight bodies ensuring ethical use of health information for research purposes only.

Revenue sharing models give users direct benefits from their data contributions, with some companies offering premium features or cash payments ($5-50 annually) to users who consent to broader data sharing for approved research studies.

Partner certification ensures data buyers meet strict criteria including institutional review board approval, legitimate research purposes, and commitments to never attempt re-identification or commercial use beyond agreed research scope.

What are the most popular niches in femtech today—fertility, pregnancy, menopause, mental health—and how do they each make money?

Fertility represents the highest-revenue niche, with companies generating income through expensive IVF services ($15,000-25,000 per cycle), employer benefit programs ($150-300 per employee annually), and premium tracking apps charging $50-100 yearly for ovulation prediction and consultation access.

Pregnancy and postpartum services monetize through subscription coaching programs ($30-60 monthly), nutritional supplement boxes ($25-50 monthly), and one-time comprehensive courses ($200-500) covering birth preparation and newborn care with high completion rates.

Menopause apps primarily use freemium models converting 5-8% of users to premium tiers ($40-80 annually) for symptom tracking, while also selling hormone-support supplements with 60%+ margins and offering specialized telehealth consultations at $75-150 per session.

Mental health platforms generate revenue through tiered subscriptions ($15-50 monthly) for cognitive behavioral therapy modules, group therapy sessions ($20-40 per session), and crisis support features, with the highest user retention rates in the FemTech sector.

Need a clear, elegant overview of a market? Browse our structured slide decks for a quick, visual deep dive.

How are femtech companies partnering with healthcare providers, insurers, or employers to drive revenue?

Employer partnerships generate the most scalable B2B revenue, with companies like Maven Clinic charging $100-300 per employee annually for fertility and family planning benefits, often seeing 15-25% employee participation rates that drive consistent recurring revenue.

Insurance partnerships focus on preventive care and chronic condition management, where FemTech apps receive $20-50 per user per month for managing conditions like PCOS or endometriosis, with reimbursement tied to user engagement and health outcomes.

Healthcare provider integrations create revenue-sharing arrangements where FemTech platforms take 20-30% commission on teleconsultations facilitated through their technology, while providers access larger patient pools and streamlined digital tools.

Pharmaceutical partnerships involve co-developing companion diagnostics and remote monitoring tools, with joint venture revenue shares typically splitting 60-40 between pharma companies and FemTech partners for successful product launches.

Clinical integration partnerships with hospitals and healthcare systems generate licensing fees of $50,000-500,000 annually for white-label solutions that improve patient engagement and reduce administrative costs in women's health departments.

If you need to-the-point data on this market, you can download our latest market pitch deck here

What new or emerging business models in femtech are expected to grow significantly in 2026?

Hybrid hardware-software bundles combining continuous monitoring devices with AI-driven subscription services are projected to capture $500 million in revenue by 2026, with products like hormone-monitoring patches paired with personalized coaching apps charging $100-200 monthly.

Decentralized clinical trial platforms will generate revenue through per-user-per-trial fees of $1,000-5,000, enabling pharmaceutical companies to recruit diverse female participants for studies while FemTech companies monetize their user bases and data infrastructure.

Personalized AI coaching subscriptions represent a micro-payment revolution, where adaptive algorithms deliver customized health advice for $5-20 weekly, creating highly granular revenue streams with conversion rates potentially reaching 15-20% due to personalization effectiveness.

Workplace wellness platforms integrating menstrual health, fertility tracking, and menopause support are expected to grow 300% in 2026, with comprehensive packages costing employers $200-400 per female employee annually for holistic women's health benefits.

Data marketplace platforms will mature to generate $100-200 million industry-wide by connecting anonymized FemTech data with pharmaceutical research, charging premium rates of $100,000-1 million per comprehensive dataset covering longitudinal health patterns.

Are there successful examples of DTC (direct-to-consumer) physical product sales in femtech—like wearables, supplements, or kits?

Elvie demonstrates successful DTC hardware sales with their breast pump ($300-500) and pelvic floor trainer ($200-300), achieving $100 million annual revenue through direct online sales, premium retail partnerships, and high-margin replacement parts generating 30% additional revenue per customer.

Daye has built a sustainable DTC subscription model delivering hormone-support supplements and testing kits monthly for $25-40, maintaining 70%+ customer retention through educational marketing and personalized product recommendations based on individual health data.

Modern Fertility captures DTC revenue through at-home hormone testing kits priced at $159-199, with 40-50% gross margins and strong repeat purchase rates driven by quarterly testing recommendations and follow-up consultation upsells at $89-150.

Supplement companies like Ritual and Care/of have successfully penetrated the FemTech space with targeted vitamin formulations for pregnancy ($30-45 monthly) and menopause ($25-35 monthly), using personalized quiz algorithms to drive conversion rates above 8-12%.

Wearable companies like Ava achieve premium DTC pricing of $200-300 for fertility tracking bracelets, enhanced by subscription app features ($5-10 monthly) and data insights that justify the higher price point compared to basic fitness trackers.

How do freemium models work in femtech, and what conversion strategies are proving effective?

FemTech freemium models gate advanced features behind premium subscriptions, with successful apps converting 5-10% of free users through strategic feature limitations that create natural upgrade triggers without frustrating basic users.

Time-limited trials offering 14-30 days of full premium access drive habit formation and increase conversion rates by 20-30%, with apps like Flo seeing higher retention when users experience advanced insights during their first menstrual cycle tracking period.

Educational content and expert webinars serve as conversion funnels, where free users attend general sessions while premium subscribers access exclusive workshops with specialists, creating perceived value that justifies $30-60 annual subscription costs.

Behavioral nudges including personalized push notifications about health insights, cycle predictions, and community discussions increase conversion rates by 25-35% when properly timed around users' health events and concerns.

Planning your next move in this new space? Start with a clean visual breakdown of market size, models, and momentum.

Conclusion

Sources

1. Vestbee FemTech Market Overview
2. Exploding Topics FemTech Startups
3. Prismetric FemTech Startup Guide
4. DLA Piper FemTech Solutions
5. 1337 Ventures FemTech Tips
6. Intrinsic FemTech Education Marketing
7. FemTech Health Market Overview
8. MHA FemTech Growth 2025